Product Information
RELPAX 40 MG TABLET is a brand product labeled by Viatris Specialty LLC, priced at $77.1517 per EA under NDC 58151036856. Its NADAC has been published 86 times since Nov 6, 2024.
Strength
40 mg/1
Manufacturer
Viatris Specialty LLCNDC
58151036856
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ELETRIPTAN HYDROBROMIDEApproval Type
New Drug (NDA)
FDA Application
NDA021016On Market Since
8/21/2024
Pharmacological Classes
Price Statistics
The NADAC for RELPAX 40 MG TABLET has been published 86 times since Nov 6, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $77.1517 per EA |
|---|---|
| All-time high | $77.5884 (Jun 11, 2025) |
| All-time low | $76.7501 (Nov 20, 2024) |
| 52-week high | $77.5344 |
| 52-week low | $77.1444 |
| Median price | $77.2279 |
| Average price | $77.2754 |
| Largest weekly change | +0.4% (Dec 18, 2024) |
| Weeks tracked | 86 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RELPAX 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RELPAX 40 MG TABLET, manufactured by Viatris Specialty LLC, is $77.1517 per EA (NDC 58151036856), effective Jun 24, 2026.
How has the price of RELPAX 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for RELPAX 40 MG TABLET has held within roughly two percent of its current level. It has been tracked across 86 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for RELPAX 40 MG TABLET?
Since Nov 6, 2024, the NADAC for RELPAX 40 MG TABLET has ranged from a low of $76.7501 (Nov 20, 2024) to a high of $77.5884 (Jun 11, 2025), with a median of $77.2279 per EA.
Are there cheaper alternatives to RELPAX 40 MG TABLET?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ELETRIPTAN HBR 40 MG TABLET, is $1.9979 per EA — about 97% below RELPAX 40 MG TABLET.
Who manufactures RELPAX 40 MG TABLET?
RELPAX 40 MG TABLET (NDC 58151036856) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification